Alpha Tau to Participate in Sidoti Small-Cap Conference
JERUSALEM, November 29, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Alpha Tau to Participate in Sidoti Small-Cap Conference
Alpha DaRT Advanced Pancreatic Cancer Trial : Highly Promising Interim Results
ATM submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT for Recurrent Head & Neck Cancer
Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
Alpha Tau to Participate in November Investor Conferences
ATM Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility
Former U.S. Commissioner of FDA Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board
Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Hadassah Medical Center
Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate Update
Alpha Tau Medical to Participate in September Investor Conferences